利索-全球专利检索

  1. 登录
  2. 注册

搜索结果

7 条记录 (耗时 0.022 秒)

    Alpha-aminoamide derivatives useful in the treatment of psychiatric disorders
    1.
    发明授权
    Alpha-aminoamide derivatives useful in the treatment of psychiatric disorders 有权
    用于治疗精神疾病的α-氨基酰胺衍生物

    公开(公告)号：US08445539B2

    公开(公告)日：2013-05-21

    申请号：US12816143

    申请日：2010-06-15

    申请人： Emanuela Izzo ,  Laura Faravelli ,  Elena Barbanti ,  Patricia Salvati

    发明人： Emanuela Izzo ,  Laura Faravelli ,  Elena Barbanti ,  Patricia Salvati

    IPC分类号： A61K31/165

    CPC分类号： A61K31/165

    摘要： The disclosure relates to pharmacotherapy of a psychiatric disorder which is schizophrenia and/or anxiety, wherein schizophrenia includes schizophrenia related disorders such as brief psychotic disorders, delusional disorders, schizoaffective disorders, and schizophreniform disorders, and anxiety includes panic disorders, obsessive-compulsive disorders (OCD), post-traumatic stress disorders (PTSD), social phobia or social anxiety disorders, specific phobia, and generalized anxiety disorders (GAD). The compounds of the disclosure are useful for the treatment of the above psychiatric disorders alone or in combination with other therapeutical agents effective in the treatment of schizophrenia and/or anxiety disorders.

    摘要翻译： 本公开涉及精神障碍和/或焦虑症的精神障碍的药物治疗，其中精神分裂症包括精神分裂症相关的疾病，例如短暂性精神病，妄想障碍，分裂情感障碍和精神分裂症样症状，焦虑包括恐慌症，强迫症（强迫症） OCD），创伤后应激障碍（PTSD），社交恐惧症或社会焦虑症，特定恐惧症和广泛性焦虑症（GAD）。 本公开的化合物可用于单独或与治​​疗精神分裂症和/或焦虑症有效的其它治疗剂组合治疗上述精神障碍。

    ALPHA-AMINOAMIDE DERIVATIVES USEFUL IN THE TREATMENT OF PSYCHIATRIC DISORDERS
    2.
    发明申请
    ALPHA-AMINOAMIDE DERIVATIVES USEFUL IN THE TREATMENT OF PSYCHIATRIC DISORDERS 有权
    用于治疗心理疾病的ALPHA-氨基腺苷衍生物

    公开(公告)号：US20110014304A1

    公开(公告)日：2011-01-20

    申请号：US12816143

    申请日：2010-06-15

    申请人： Emanuela Izzo ,  Laura Faravelli ,  Elena Barbanti ,  Patricia Salvati

    发明人： Emanuela Izzo ,  Laura Faravelli ,  Elena Barbanti ,  Patricia Salvati

    IPC分类号： A61K31/165 ,  A61K31/551 ,  A61K31/496 ,  A61K31/4515 ,  A61K31/519 ,  A61K33/00 ,  A61K31/53 ,  A61P25/00 ,  A61P25/18 ,  A61P25/22

    CPC分类号： A61K31/165

    摘要： The disclosure relates to pharmacotherapy of a psychiatric disorder which is schizophrenia and/or anxiety, wherein schizophrenia includes schizophrenia related disorders such as brief psychotic disorders, delusional disorders, schizoaffective disorders, and schizophreniform disorders, and anxiety includes panic disorders, obsessive-compulsive disorders (OCD), post-traumatic stress disorders (PTSD), social phobia or social anxiety disorders, specific phobia, and generalized anxiety disorders (GAD). The compounds of the disclosure are useful for the treatment of the above psychiatric disorders alone or in combination with other therapeutical agents effective in the treatment of schizophrenia and/or anxiety disorders.

    摘要翻译： 本公开涉及精神障碍和/或焦虑症的精神障碍的药物治疗，其中精神分裂症包括精神分裂症相关的疾病，例如短暂性精神病，妄想障碍，分裂情感障碍和精神分裂症样症状，焦虑包括恐慌症，强迫症（强迫症） OCD），创伤后应激障碍（PTSD），社交恐惧症或社会焦虑症，特定恐惧症和广泛性焦虑症（GAD）。 本公开的化合物可用于单独或与治​​疗精神分裂症和/或焦虑症有效的其它治疗剂组合治疗上述精神障碍。